|
71
|
240
|
5laiC |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
57
|
202
|
5lf7N |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
59
|
204
|
5laiI |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
70
|
212
|
5bxlK |
Yeast 20s proteasome beta2-g170a mutant |
|
67
|
233
|
5l5jM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
62
|
222
|
5l61L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
65
|
216
|
5lf1M |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
62
|
211
|
5l5zK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
57
|
204
|
5l6bI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
239
|
5le5F |
Native human 20s proteasome at 1.8 angstrom |
|
65
|
240
|
5l5iC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
71
|
243
|
5l5wF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
63
|
241
|
5laiG |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
75
|
212
|
5l55K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
59
|
196
|
5l65N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
71
|
222
|
5lcfA |
Vim-2 metallo-beta-lactamase in complex with 3-oxo-2-phenylisoindoline-4-carboxylic acid (compound 30) |
|
64
|
244
|
5lexG |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
64
|
241
|
5l52G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
57
|
204
|
5l54I |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
67
|
233
|
5l5oM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
250
|
5laiA |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5l52E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
71
|
240
|
5l65C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
56
|
204
|
5lf3I |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
62
|
211
|
5l5oK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
243
|
5l5zF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
242
|
5l5vD |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
228
|
5lajM |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
234
|
5lf1E |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
58
|
204
|
5l5oI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
233
|
5l69M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
233
|
5laiM |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5lttE |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
67
|
242
|
5l5zD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
231
|
5l68E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
63
|
241
|
5l5dG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
195
|
5l66J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
211
|
5l63K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
196
|
5lajN |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
213
|
5le5L |
Native human 20s proteasome at 1.8 angstrom |
|
67
|
250
|
5l54A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
70
|
244
|
5l5sB |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
71
|
244
|
5l5wB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
71
|
243
|
5laiF |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
200
|
5lf6K |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
195
|
5l5rJ |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
58
|
195
|
5l61J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
58
|
196
|
5l69N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
73
|
248
|
5lf0B |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
60
|
222
|
5l5pL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
